Published in:
Open Access 01-09-2021 | Mood Disorders | Editorial
Generalised Anxiety Disorder and Depression: Contemporary Treatment Approaches
Published in: Advances in Therapy | Special Issue 2/2021
Login to get accessExcerpt
|
Why carry out this review?
|
|
Generalised anxiety disorder (GAD) and major depressive disorder (MDD) form part of a large group of prevalent psychiatric disorders, and are frequently comorbid.
|
|
These manuscripts describe presentations from a virtual symposium titled “GAD and Depression: Contemporary Treatment Approaches” as part of the Industry Science Exchange sessions that took place as at the European College of Neuropsychopharmacology 33rd Congress in September 2020.
|
|
What was learned from the review?
|
|
Selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors are considered first-line therapy in patients with GAD, but agents with a different mechanism of action may also be considered in those who do not respond to or tolerate these therapies.
|
|
Patients with MDD with symptoms of GAD, also referred to as anxious depression, should be managed with an antidepressant that has anti-anxiety effects.
|
|
Greater recognition of anxious depression is needed as this condition is often accompanied by increased suicidality and the need for more robust treatment.
|